Global Mesalazine API Market Research Report 2025(Status and Outlook)

March 2025 | 229 pages | ID: G92AA1534843EN
Bosson Research

Abstracts

Report Overview

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

This report provides a deep insight into the global Mesalazine API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Mesalazine API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Mesalazine API market in any manner.

Global Mesalazine API Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

PharmaZell

Syntese A/S

Cambrex Corporation

Divis Laboratories

Chemi SpA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Market Segmentation (by Type)

Above 97 %

Above 98 %

Above 99 %

Market Segmentation (by Application)

Tablets

Capsules

Granule

Suppository

Enema

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Mesalazine API Market
• Overview of the regional outlook of the Mesalazine API Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Mesalazine API Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Mesalazine API
1.2 Key Market Segments
  1.2.1 Mesalazine API Segment by Type
  1.2.2 Mesalazine API Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL MESALAZINE API MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Mesalazine API Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Mesalazine API Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL MESALAZINE API MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Mesalazine API Product Life Cycle
3.3 Global Mesalazine API Sales by Manufacturers (2020-2025)
3.4 Global Mesalazine API Revenue Market Share by Manufacturers (2020-2025)
3.5 Mesalazine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Mesalazine API Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Mesalazine API Manufacturing Sites, Area Served, Product Type
3.8 Mesalazine API Market Competitive Situation and Trends
  3.8.1 Mesalazine API Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Mesalazine API Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MESALAZINE API INDUSTRY CHAIN ANALYSIS

4.1 Mesalazine API Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MESALAZINE API MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Mesalazine API Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Mesalazine API Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL MESALAZINE API MARKET BY REGION

6.1 Global Mesalazine API Market Size by Region
  6.1.1 Global Mesalazine API Market Size by Region
  6.1.2 Global Mesalazine API Market Size Market Share by Region
6.2 Global Mesalazine API Sales by Region
  6.2.1 Global Mesalazine API Sales by Region
  6.2.2 Global Mesalazine API Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Mesalazine API Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Mesalazine API Market Size by Type
7.3 North America Mesalazine API Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Mesalazine API Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Mesalazine API Market Size by Type
8.3 Europe Mesalazine API Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Mesalazine API Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Mesalazine API Market Size by Type
9.3 Asia-Pacific Mesalazine API Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Mesalazine API Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Mesalazine API Market Size by Type
10.3 South America Mesalazine API Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Mesalazine API Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Mesalazine API Market Size by Type
11.3 Middle East and Africa Mesalazine API Market Size by Application

12 MESALAZINE API MARKET PRODUCTION BY REGION

12.1 Global Production of Mesalazine API by Region(2020-2025)
12.2 Global Mesalazine API Revenue Market Share by Region (2020-2025)
12.3 Global Mesalazine API Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Mesalazine API Production
  12.4.1 North America Mesalazine API Production Growth Rate (2020-2025)
  12.4.2 North America Mesalazine API Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Mesalazine API Production
  12.5.1 Europe Mesalazine API Production Growth Rate (2020-2025)
  12.5.2 Europe Mesalazine API Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Mesalazine API Production (2020-2025)
  12.6.1 Japan Mesalazine API Production Growth Rate (2020-2025)
  12.6.2 Japan Mesalazine API Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Mesalazine API Production (2020-2025)
  12.7.1 China Mesalazine API Production Growth Rate (2020-2025)
  12.7.2 China Mesalazine API Production, Revenue, Price and Gross Margin (2020-2025)

13 MESALAZINE API MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Mesalazine API Sales Market Share by Type (2020-2033)
13.3 Global Mesalazine API Market Size Market Share by Type (2020-2033)
13.4 Global Mesalazine API Price by Type (2020-2033)

14 MESALAZINE API MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Mesalazine API Market Sales by Application (2020-2033)
14.3 Global Mesalazine API Market Size (M USD) by Application (2020-2033)
14.4 Global Mesalazine API Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 PharmaZell
  15.1.1 PharmaZell Basic Information
  15.1.2 PharmaZell Mesalazine API Product Overview
  15.1.3 PharmaZell Mesalazine API Product Market Performance
  15.1.4 PharmaZell Business Overview
  15.1.5 PharmaZell SWOT Analysis
  15.1.6 PharmaZell Recent Developments
15.2 Syntese A/S
  15.2.1 Syntese A/S Basic Information
  15.2.2 Syntese A/S Mesalazine API Product Overview
  15.2.3 Syntese A/S Mesalazine API Product Market Performance
  15.2.4 Syntese A/S Business Overview
  15.2.5 Syntese A/S SWOT Analysis
  15.2.6 Syntese A/S Recent Developments
15.3 Cambrex Corporation
  15.3.1 Cambrex Corporation Basic Information
  15.3.2 Cambrex Corporation Mesalazine API Product Overview
  15.3.3 Cambrex Corporation Mesalazine API Product Market Performance
  15.3.4 Cambrex Corporation Business Overview
  15.3.5 Cambrex Corporation SWOT Analysis
  15.3.6 Cambrex Corporation Recent Developments
15.4 Divis Laboratories
  15.4.1 Divis Laboratories Basic Information
  15.4.2 Divis Laboratories Mesalazine API Product Overview
  15.4.3 Divis Laboratories Mesalazine API Product Market Performance
  15.4.4 Divis Laboratories Business Overview
  15.4.5 Divis Laboratories Recent Developments
15.5 Chemi SpA
  15.5.1 Chemi SpA Basic Information
  15.5.2 Chemi SpA Mesalazine API Product Overview
  15.5.3 Chemi SpA Mesalazine API Product Market Performance
  15.5.4 Chemi SpA Business Overview
  15.5.5 Chemi SpA Recent Developments
15.6 Ipca Laboratories
  15.6.1 Ipca Laboratories Basic Information
  15.6.2 Ipca Laboratories Mesalazine API Product Overview
  15.6.3 Ipca Laboratories Mesalazine API Product Market Performance
  15.6.4 Ipca Laboratories Business Overview
  15.6.5 Ipca Laboratories Recent Developments
15.7 Hangzhou Brother
  15.7.1 Hangzhou Brother Basic Information
  15.7.2 Hangzhou Brother Mesalazine API Product Overview
  15.7.3 Hangzhou Brother Mesalazine API Product Market Performance
  15.7.4 Hangzhou Brother Business Overview
  15.7.5 Hangzhou Brother Recent Developments
15.8 Lianyungang Fengheng Biopharm
  15.8.1 Lianyungang Fengheng Biopharm Basic Information
  15.8.2 Lianyungang Fengheng Biopharm Mesalazine API Product Overview
  15.8.3 Lianyungang Fengheng Biopharm Mesalazine API Product Market Performance
  15.8.4 Lianyungang Fengheng Biopharm Business Overview
  15.8.5 Lianyungang Fengheng Biopharm Recent Developments
15.9 Lasa Loboratory
  15.9.1 Lasa Loboratory Basic Information
  15.9.2 Lasa Loboratory Mesalazine API Product Overview
  15.9.3 Lasa Loboratory Mesalazine API Product Market Performance
  15.9.4 Lasa Loboratory Business Overview
  15.9.5 Lasa Loboratory Recent Developments
15.10 Corden Pharma Bergamo
  15.10.1 Corden Pharma Bergamo Basic Information
  15.10.2 Corden Pharma Bergamo Mesalazine API Product Overview
  15.10.3 Corden Pharma Bergamo Mesalazine API Product Market Performance
  15.10.4 Corden Pharma Bergamo Business Overview
  15.10.5 Corden Pharma Bergamo Recent Developments
15.11 Erregierre SpA
  15.11.1 Erregierre SpA Basic Information
  15.11.2 Erregierre SpA Mesalazine API Product Overview
  15.11.3 Erregierre SpA Mesalazine API Product Market Performance
  15.11.4 Erregierre SpA Business Overview
  15.11.5 Erregierre SpA Recent Developments
15.12 CTX Lifescience
  15.12.1 CTX Lifescience Basic Information
  15.12.2 CTX Lifescience Mesalazine API Product Overview
  15.12.3 CTX Lifescience Mesalazine API Product Market Performance
  15.12.4 CTX Lifescience Business Overview
  15.12.5 CTX Lifescience Recent Developments
15.13 Ishita Active Pharma Ingredients
  15.13.1 Ishita Active Pharma Ingredients Basic Information
  15.13.2 Ishita Active Pharma Ingredients Mesalazine API Product Overview
  15.13.3 Ishita Active Pharma Ingredients Mesalazine API Product Market Performance
  15.13.4 Ishita Active Pharma Ingredients Business Overview
  15.13.5 Ishita Active Pharma Ingredients Recent Developments
15.14 YC Biotech (Jiangsu)
  15.14.1 YC Biotech (Jiangsu) Basic Information
  15.14.2 YC Biotech (Jiangsu) Mesalazine API Product Overview
  15.14.3 YC Biotech (Jiangsu) Mesalazine API Product Market Performance
  15.14.4 YC Biotech (Jiangsu) Business Overview
  15.14.5 YC Biotech (Jiangsu) Recent Developments
15.15 Xinxiang Tianfeng Fine Chemical
  15.15.1 Xinxiang Tianfeng Fine Chemical Basic Information
  15.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Overview
  15.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Market Performance
  15.15.4 Xinxiang Tianfeng Fine Chemical Business Overview
  15.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Mesalazine API Market Size by Type (M USD)
Table 4. Global Mesalazine API Market Size by Application (M USD)
Table 5. Mesalazine API Market Size Comparison by Region (M USD)
Table 6. Global Mesalazine API Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Mesalazine API Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Mesalazine API Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Mesalazine API Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine API as of 2024)
Table 11. Global Market Mesalazine API Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Mesalazine API Manufacturing Sites and Area Served
Table 13. Manufacturers Mesalazine API Product Type
Table 14. Global Mesalazine API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Mesalazine API Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Mesalazine API Market Size Comparison by Region (M USD)
Table 26. Global Mesalazine API Market Size by Region (2020-2033) & (M USD)
Table 27. Global Mesalazine API Market Size Market Share by Region (2020-2033)
Table 28. Global Mesalazine API Sales by Region (2020-2033) & (K MT)
Table 29. Global Mesalazine API Sales Market Share by Region (2020-2033)
Table 30. North America Mesalazine API Market Size by Country (2020-2033) & (M USD)
Table 31. North America Mesalazine API Sales by Country (2020-2033) & (K MT)
Table 32. North America Mesalazine API Sales by Type (K MT)
Table 33. North America Mesalazine API Market Size by Type (M USD)
Table 34. North America Mesalazine API Sales (K MT) by Type (2020-2033)
Table 35. North America Mesalazine API Market Size (M USD) by Type (2020-2033)
Table 36. North America Mesalazine API Sales by Application (K MT)
Table 37. North America Mesalazine API Market Size by Application (M USD)
Table 38. North America Mesalazine API Sales (K MT) by Application (2020-2033)
Table 39. North America Mesalazine API Market Size (M USD) by Application (2020-2033)
Table 40. Europe Mesalazine API Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Mesalazine API Sales by Country (2020-2033) & (K MT)
Table 42. Europe Mesalazine API Sales by Type (K MT)
Table 43. Europe Mesalazine API Market Size by Type (M USD)
Table 44. Europe Mesalazine API Sales (K MT) by Type (2020-2033)
Table 45. Europe Mesalazine API Market Size (M USD) by Type (2020-2033)
Table 46. Europe Mesalazine API Sales by Application (K MT)
Table 47. Europe Mesalazine API Market Size by Application (M USD)
Table 48. Europe Mesalazine API Sales (K MT) by Application (2020-2033)
Table 49. Europe Mesalazine API Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Mesalazine API Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Mesalazine API Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Mesalazine API Sales by Type (K MT)
Table 53. Asia-Pacific Mesalazine API Market Size by Type (M USD)
Table 54. Asia-Pacific Mesalazine API Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Mesalazine API Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Mesalazine API Sales by Application (K MT)
Table 57. Asia-Pacific Mesalazine API Market Size by Application (M USD)
Table 58. Asia-Pacific Mesalazine API Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Mesalazine API Market Size (M USD) by Application (2020-2025)
Table 60. South America Mesalazine API Market Size by Country (2020-2033) & (M USD)
Table 61. South America Mesalazine API Sales by Country (2020-2033) & (K MT)
Table 62. South America Mesalazine API Sales by Type (K MT)
Table 63. South America Mesalazine API Market Size by Type (M USD)
Table 64. South America Mesalazine API Sales (K MT) by Type (2020-2033)
Table 65. South America Mesalazine API Market Size (M USD) by Type (2020-2033)
Table 66. South America Mesalazine API Sales by Application (K MT)
Table 67. South America Mesalazine API Market Size by Application (M USD)
Table 68. South America Mesalazine API Sales (K MT) by Application (2020-2033)
Table 69. South America Mesalazine API Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Mesalazine API Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Mesalazine API Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Mesalazine API Sales by Type (K MT)
Table 73. Middle East and Africa Mesalazine API Market Size by Type (M USD)
Table 74. Middle East and Africa Mesalazine API Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Mesalazine API Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Mesalazine API Sales by Application (K MT)
Table 77. Middle East and Africa Mesalazine API Market Size by Application (M USD)
Table 78. Middle East and Africa Mesalazine API Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Mesalazine API Market Size (M USD) by Application (2020-2033)
Table 80. Global Mesalazine API Production (K MT) by Region(2020-2025)
Table 81. Global Mesalazine API Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Mesalazine API Revenue Market Share by Region (2020-2025)
Table 83. Global Mesalazine API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Mesalazine API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Mesalazine API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Mesalazine API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Mesalazine API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Mesalazine API Sales by Type (K MT)
Table 89. Global Mesalazine API Market Size by Type (M USD)
Table 90. Global Mesalazine API Sales (K MT) by Type (2020-2033)
Table 91. Global Mesalazine API Sales Market Share by Type (2020-2033)
Table 92. Global Mesalazine API Market Size (M USD) by Type (2020-2033)
Table 93. Global Mesalazine API Market Size Share by Type (2020-2033)
Table 94. Global Mesalazine API Sales (K MT) by Application
Table 95. Global Mesalazine API Market Size by Application(M USD)
Table 96. Global Mesalazine API Sales by Application (2020-2033) & (K MT)
Table 97. Global Mesalazine API Sales Market Share by Application (2020-2033)
Table 98. Global Mesalazine API Market Size by Application (2020-2033) & (M USD)
Table 99. Global Mesalazine API Market Share by Application (2020-2033)
Table 100. Global Mesalazine API Sales Growth Rate by Application (2020-2033)
Table 101. PharmaZell Basic Information
Table 102. PharmaZell Mesalazine API Product Overview
Table 103. PharmaZell Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. PharmaZell Business Overview
Table 105. PharmaZell SWOT Analysis
Table 106. PharmaZell Recent Developments
Table 107. Syntese A/S Basic Information
Table 108. Syntese A/S Mesalazine API Product Overview
Table 109. Syntese A/S Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Syntese A/S Business Overview
Table 111. Syntese A/S SWOT Analysis
Table 112. Syntese A/S Recent Developments
Table 113. Cambrex Corporation Basic Information
Table 114. Cambrex Corporation Mesalazine API Product Overview
Table 115. Cambrex Corporation Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Cambrex Corporation Business Overview
Table 117. Cambrex Corporation SWOT Analysis
Table 118. Cambrex Corporation Recent Developments
Table 119. Divis Laboratories Basic Information
Table 120. Divis Laboratories Mesalazine API Product Overview
Table 121. Divis Laboratories Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Divis Laboratories Business Overview
Table 123. Divis Laboratories Recent Developments
Table 124. Chemi SpA Basic Information
Table 125. Chemi SpA Mesalazine API Product Overview
Table 126. Chemi SpA Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Chemi SpA Business Overview
Table 128. Chemi SpA Recent Developments
Table 129. Ipca Laboratories Basic Information
Table 130. Ipca Laboratories Mesalazine API Product Overview
Table 131. Ipca Laboratories Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Ipca Laboratories Business Overview
Table 133. Ipca Laboratories Recent Developments
Table 134. Hangzhou Brother Basic Information
Table 135. Hangzhou Brother Mesalazine API Product Overview
Table 136. Hangzhou Brother Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Hangzhou Brother Business Overview
Table 138. Hangzhou Brother Recent Developments
Table 139. Lianyungang Fengheng Biopharm Basic Information
Table 140. Lianyungang Fengheng Biopharm Mesalazine API Product Overview
Table 141. Lianyungang Fengheng Biopharm Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Lianyungang Fengheng Biopharm Business Overview
Table 143. Lianyungang Fengheng Biopharm Recent Developments
Table 144. Lasa Loboratory Basic Information
Table 145. Lasa Loboratory Mesalazine API Product Overview
Table 146. Lasa Loboratory Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Lasa Loboratory Business Overview
Table 148. Lasa Loboratory Recent Developments
Table 149. Corden Pharma Bergamo Basic Information
Table 150. Corden Pharma Bergamo Mesalazine API Product Overview
Table 151. Corden Pharma Bergamo Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Corden Pharma Bergamo Business Overview
Table 153. Corden Pharma Bergamo Recent Developments
Table 154. Erregierre SpA Basic Information
Table 155. Erregierre SpA Mesalazine API Product Overview
Table 156. Erregierre SpA Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Erregierre SpA Business Overview
Table 158. Erregierre SpA Recent Developments
Table 159. CTX Lifescience Basic Information
Table 160. CTX Lifescience Mesalazine API Product Overview
Table 161. CTX Lifescience Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. CTX Lifescience Business Overview
Table 163. CTX Lifescience Recent Developments
Table 164. Ishita Active Pharma Ingredients Basic Information
Table 165. Ishita Active Pharma Ingredients Mesalazine API Product Overview
Table 166. Ishita Active Pharma Ingredients Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Ishita Active Pharma Ingredients Business Overview
Table 168. Ishita Active Pharma Ingredients Recent Developments
Table 169. YC Biotech (Jiangsu) Basic Information
Table 170. YC Biotech (Jiangsu) Mesalazine API Product Overview
Table 171. YC Biotech (Jiangsu) Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. YC Biotech (Jiangsu) Business Overview
Table 173. YC Biotech (Jiangsu) Recent Developments
Table 174. Xinxiang Tianfeng Fine Chemical Basic Information
Table 175. Xinxiang Tianfeng Fine Chemical Mesalazine API Product Overview
Table 176. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Xinxiang Tianfeng Fine Chemical Business Overview
Table 178. Xinxiang Tianfeng Fine Chemical Recent Developments
List of Figures
Figure 1. Product Picture of Mesalazine API
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Mesalazine API Market Size (M USD), 2024-2033
Figure 5. Global Mesalazine API Market Size (M USD) (2020-2033)
Figure 6. Global Mesalazine API Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Mesalazine API Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Mesalazine API Product Life Cycle
Figure 13. Mesalazine API Sales Share by Manufacturers in 2024
Figure 14. Global Mesalazine API Revenue Share by Manufacturers in 2024
Figure 15. Mesalazine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Mesalazine API Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Mesalazine API Revenue in 2024
Figure 18. Industry Chain Map of Mesalazine API
Figure 19. Global Mesalazine API Market PEST Analysis
Figure 20. Global Mesalazine API Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Mesalazine API Market Size by Region
Figure 27. Global Mesalazine API Market Size Market Share by Region (2020-2033)
Figure 28. Global Mesalazine API Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Mesalazine API Market Size (M USD) by Country
Figure 33. USA Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Mesalazine API Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Mesalazine API Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Mesalazine API Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Mesalazine API Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Mesalazine API Market Size (M USD)by Type
Figure 40. North America Mesalazine API Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Mesalazine API Market Size (M USD) by Country
Figure 45. Germany Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Mesalazine API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Mesalazine API Market Size (M USD) by Type
Figure 56. Europe Mesalazine API Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Mesalazine API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Mesalazine API Market Size (M USD) by Country
Figure 61. China Mesalazine API Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Mesalazine API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Mesalazine API Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Mesalazine API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Mesalazine API Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Mesalazine API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Mesalazine API Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Mesalazine API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Mesalazine API Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Mesalazine API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Mesalazine API Market Size (M USD) by Type
Figure 72. Asia-Pacific Mesalazine API Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Mesalazine API Market Size (M USD) by Country
Figure 77. Brazil Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Mesalazine API Market Size (M USD) by Type
Figure 84. South America Mesalazine API Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Mesalazine API Market Size (M USD) by Country
Figure 89. Saudi Arabia Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Mesalazine API Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Mesalazine API Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Mesalazine API Market Size (M USD) by Type
Figure 100. Middle East and Africa Mesalazine API Market Size (M USD) by Application
Figure 101. Global Mesalazine API Production Market Share by Region (2020-2025)
Figure 102. North America Mesalazine API Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Mesalazine API Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Mesalazine API Production (K MT) Growth Rate (2020-2025)
Figure 105. China Mesalazine API Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Mesalazine API Market Size by Type (M USD)
Figure 108. Sales Market Share of Mesalazine API by Type (2020-2033)
Figure 109. Sales Market Share of Mesalazine API by Type in 2024
Figure 110. Market Size Share of Mesalazine API by Type (2020-2033)
Figure 111. Market Size Share of Mesalazine API by Type in 2024
Figure 112. Global Mesalazine API Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Mesalazine API Market Size by Application(M USD)
Figure 115. Global Mesalazine API Market Share by Application
Figure 116. Global Mesalazine API Sales Market Share by Application (2020-2033)
Figure 117. Global Mesalazine API Sales Market Share by Application in 2024
Figure 118. Global Mesalazine API Market Share by Application (2020-2033)
Figure 119. Global Mesalazine API Market Share by Application in 2024
Figure 120. Global Mesalazine API Sales Growth Rate by Application (2020-2033)